Cargando…
Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684840/ https://www.ncbi.nlm.nih.gov/pubmed/26770854 http://dx.doi.org/10.1155/2015/137270 |
_version_ | 1782406215498727424 |
---|---|
author | Doguizi, Sibel Sekeroglu, Mehmet Ali Anayol, Mustafa Alpaslan Yilmazbas, Pelin |
author_facet | Doguizi, Sibel Sekeroglu, Mehmet Ali Anayol, Mustafa Alpaslan Yilmazbas, Pelin |
author_sort | Doguizi, Sibel |
collection | PubMed |
description | Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old boy presented with a complaint of low visual acuity (best corrected visual acuity: 20/80 in both eyes, refractive error: −12.00 D). Dilated fundus examination revealed multiple bilateral, sharply defined, and scalloped chorioretinal atrophy areas in the midperipheral and peripheral zone. Spectral-domain optical coherence tomography revealed bilateral cystoid macular edema in both eyes. Serum ornithine level was high (622 μmol/L). An arginine-restricted diet reduced serum ornithine level (55 μmol/L). However, visual findings including macular edema remained unchanged in 2 years of follow-up. Conclusion. Arginine-restricted diet did not improve macular edema in our patient with gyrate atrophy. A more comprehensive understanding of the underlying factors for macular edema will lead to the development of effective therapies. |
format | Online Article Text |
id | pubmed-4684840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46848402016-01-14 Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy Doguizi, Sibel Sekeroglu, Mehmet Ali Anayol, Mustafa Alpaslan Yilmazbas, Pelin Case Rep Ophthalmol Med Case Report Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old boy presented with a complaint of low visual acuity (best corrected visual acuity: 20/80 in both eyes, refractive error: −12.00 D). Dilated fundus examination revealed multiple bilateral, sharply defined, and scalloped chorioretinal atrophy areas in the midperipheral and peripheral zone. Spectral-domain optical coherence tomography revealed bilateral cystoid macular edema in both eyes. Serum ornithine level was high (622 μmol/L). An arginine-restricted diet reduced serum ornithine level (55 μmol/L). However, visual findings including macular edema remained unchanged in 2 years of follow-up. Conclusion. Arginine-restricted diet did not improve macular edema in our patient with gyrate atrophy. A more comprehensive understanding of the underlying factors for macular edema will lead to the development of effective therapies. Hindawi Publishing Corporation 2015 2015-12-06 /pmc/articles/PMC4684840/ /pubmed/26770854 http://dx.doi.org/10.1155/2015/137270 Text en Copyright © 2015 Sibel Doguizi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Doguizi, Sibel Sekeroglu, Mehmet Ali Anayol, Mustafa Alpaslan Yilmazbas, Pelin Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title | Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title_full | Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title_fullStr | Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title_full_unstemmed | Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title_short | Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy |
title_sort | arginine-restricted therapy resistant bilateral macular edema associated with gyrate atrophy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684840/ https://www.ncbi.nlm.nih.gov/pubmed/26770854 http://dx.doi.org/10.1155/2015/137270 |
work_keys_str_mv | AT doguizisibel argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy AT sekeroglumehmetali argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy AT anayolmustafaalpaslan argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy AT yilmazbaspelin argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy |